Trials / Completed
CompletedNCT05452863
O2matic Cardiology Protocol
Automatic Oxygen Supply With the O2matic Device for the Treatment of Hospitalized Heart Patients With Hypoxia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Hvidovre University Hospital · Academic / Other
- Sex
- All
- Age
- 30 Years
- Healthy volunteers
- Not accepted
Summary
Automatic oxygen supply with the O2matic device has been shown to provided an enhanced oxygen treatment in patients with hypoxemia. O2matic was significantly better than manual control to maintain oxygen saturation within target interval and to reduce time with unintended hypoxemia in patients suffering from chronic obstructive pulmonary disease. This trial investigates the effect of using O2matic in hypoxic patients submitted to the Department of Cardiology.
Detailed description
Oxygen supply to patients with cardiovascular disease has been subject to several investigations. Both too much and too little oxygen is supposed to be harmful. The O2matic device is a new way of supplying oxygen treatment which is significantly better than manual control to maintain oxygen saturation within target interval and to reduce time with unintended hypoxemia. The device has past favorable tests in patients suffering from chronic obstructive pulmonary disease. This study investigates the application of the O2matic device on hypoxic patients admitted to the Cardiology ward.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | O2matic administered oxygen | Oxygen supply is adjusted from an almost continuous measurement of the oxygen saturation with an appropriate an previously tested algorithm. |
| DEVICE | Manual oxygen supply and adjustments | Oxygen supply is adjusted from manual measurements of the oxygen saturation |
Timeline
- Start date
- 2022-03-01
- Primary completion
- 2023-03-18
- Completion
- 2024-03-18
- First posted
- 2022-07-11
- Last updated
- 2024-09-19
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT05452863. Inclusion in this directory is not an endorsement.